Lenskart Eyes $10 Bn Valuation, Plans For a Billion-Dollar IPO: Report Lenskart is reportedly planning to raise USD 1 billion and eyeing a USD 10 billion valuation with plans to file draft papers with the market regulator Securities and Exchange Board of India (SEBI) in May this year.

By Entrepreneur Staff

You're reading Entrepreneur India, an international franchise of Entrepreneur Media.

Peyush Bansal

Lenskart is reportedly planning to raise USD 1 billion and eyeing a USD 10 billion valuation with plans to file draft papers with the market regulator Securities and Exchange Board of India (SEBI) in May this year.

Company's chief executive Peyush Bansal and key investors in the company have reportedly discussed matters around valuation with the banking institutions managing the potential billion-dollar listing according to a report by the Economic Times, citing informed sources.

However, the report said that the plans to go public are still based on market conditions closer to tentative dates.

The company valuation that Lenskart is eyeing will be double its value during the last Series I USD 262 million plus an undisclosed sum funding round led by the likes of ChrysCapital, Infinity Partners, Chiratae Ventures, and Aditya Birla Capital.

According to the report, the source told ET that Lenskart has already started working on filing the draft red herring prospectus (DRHP) in order to hit the market in 2025 and that top-brass at the company feels even more optimistic in terms of the planned valuation but this might not align with the prevailing market conditions. The source reportedly said this was to leave some room for the investors who come in through the IPO itself.

Another source as claimed said that there might not be enough time left for a pre-IPO fundraise, with the company fully ready to go public.

The eye-wear retail unicorn, currently Series I has previously raised USD 231 million in Series G funding from Tokyo-based SoftBank Vision Fund in its largest-ever funding-round in 2019. This was followed by another USD 220 million in 2021 led by Alpha Wave Global, Temasek, Chiratae Ventures, Technology Venture Partners, IFC, and Bay Capital with financial services firm Avendus facilitating both rounds, according to Tracxn.

The 2021 funding round took Lenskart to a valuation of USD 2.4 billion with recorded revenue of USD 165 million, almost double the USD 1.4 billion in 2019. The company is now at USD 5.6 billion in valuation as of November 2024, with the FY2023-24 revenue recorded at USD 678.8 million.

Lenskart currently is the market leader in its sector in India with a 79 per cent market share with retail stores across Southeast Asia, the Middle East, and the USA. The company's recent focus on the mass premium eyewear segment has also allowed it to compete with players such as the Titan Eye.

Entrepreneur Staff

Entrepreneur Staff

Editor

For more than 30 years, Entrepreneur has set the course for success for millions of entrepreneurs and small business owners. We'll teach you the secrets of the winners and give you exactly what you need to lay the groundwork for success.
Leadership

The Difference Between Entrepreneurs Who Survive Crises and Those Who Don't

In a business world accelerated by AI, visibility alone is fragile. Here's how strategic silence and consistency can turn reputation into your most powerful asset.

Business Ideas

70 Small Business Ideas to Start in 2025

We put together a list of the best, most profitable small business ideas for entrepreneurs to pursue in 2025.

News and Trends

How Lab-Grown Diamonds are Reshaping Jewellery Market

As sustainability takes the centre stage shaping the luxury market, lab grown diamonds (LGDs) are leading the way and not merely following the latest trends, says Ishendra Agarwal, Founder, Giva

Business News

AI Could Cause 99% of All Workers to Be Unemployed in the Next Five Years, Says Computer Science Professor

Professor Roman Yampolskiy predicted that artificial general intelligence would be developed and used by 2030, leading to mass automation.

News and Trends

Reveal HealthTech Raises USD 7.2 Mn to Expand AI-Driven Healthcare Solutions

The fresh funding will be channelled towards scaling its flagship products, BioCanvas and Prism AI.